Syngene International Limited (NSE:SYNGENE)
448.00
+6.00 (1.36%)
Jun 1, 2026, 3:30 PM IST
Syngene International Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 37,387 | 36,424 | 34,886 | 31,929 | 26,042 | |
Revenue Growth (YoY) | 2.64% | 4.41% | 9.26% | 22.61% | 19.22% |
Cost of Revenue | 9,186 | 12,014 | 11,386 | 10,368 | 8,921 |
Gross Profit | 28,201 | 24,410 | 23,500 | 21,561 | 17,121 |
Selling, General & Admin | 11,049 | 10,298 | 9,397 | 8,929 | 7,496 |
Other Operating Expenses | 7,358 | 3,616 | 3,370 | 2,785 | 2,184 |
Operating Expenses | 22,936 | 18,270 | 17,032 | 15,389 | 12,785 |
Operating Income | 5,265 | 6,140 | 6,468 | 6,172 | 4,336 |
Interest Expense | -488 | -531 | -472 | -452 | -241 |
Interest & Investment Income | - | 559 | 761 | 603 | 465 |
Currency Exchange Gain (Loss) | -609 | -19 | -558 | -418 | 548 |
Other Non Operating Income (Expenses) | 707 | - | 1 | - | - |
EBT Excluding Unusual Items | 4,875 | 6,149 | 6,200 | 5,905 | 5,108 |
Merger & Restructuring Charges | - | - | -111 | - | - |
Gain (Loss) on Sale of Investments | - | 159 | 144 | 106 | 63 |
Asset Writedown | - | -29 | -25 | -75 | -20 |
Other Unusual Items | -766 | - | - | - | -307 |
Pretax Income | 4,109 | 6,599 | 6,208 | 5,936 | 4,844 |
Income Tax Expense | 942 | 1,637 | 1,108 | 1,292 | 886 |
Net Income | 3,167 | 4,962 | 5,100 | 4,644 | 3,958 |
Net Income to Common | 3,167 | 4,962 | 5,100 | 4,644 | 3,958 |
Net Income Growth | -36.18% | -2.71% | 9.82% | 17.33% | -2.25% |
Shares Outstanding (Basic) | 402 | 402 | 401 | 401 | 398 |
Shares Outstanding (Diluted) | 402 | 402 | 402 | 404 | 403 |
Shares Change (YoY) | 0.02% | 0.09% | -0.41% | 0.18% | 0.56% |
EPS (Basic) | 7.87 | 12.35 | 12.71 | 11.59 | 9.94 |
EPS (Diluted) | 7.87 | 12.34 | 12.69 | 11.51 | 9.82 |
EPS Growth | -36.22% | -2.76% | 10.25% | 17.21% | -2.87% |
Free Cash Flow | 5,712 | 4,073 | 5,501 | 3,169 | 1,053 |
Free Cash Flow Per Share | 14.19 | 10.12 | 13.69 | 7.85 | 2.61 |
Dividend Per Share | 1.250 | 1.250 | 1.250 | 0.500 | 0.500 |
Dividend Growth | - | - | 150.00% | - | - |
Gross Margin | 75.43% | 67.02% | 67.36% | 67.53% | 65.74% |
Operating Margin | 14.08% | 16.86% | 18.54% | 19.33% | 16.65% |
Profit Margin | 8.47% | 13.62% | 14.62% | 14.54% | 15.20% |
Free Cash Flow Margin | 15.28% | 11.18% | 15.77% | 9.93% | 4.04% |
EBITDA | 9,794 | 9,912 | 10,301 | 9,593 | 7,256 |
EBITDA Margin | 26.20% | 27.21% | 29.53% | 30.04% | 27.86% |
D&A For EBITDA | 4,529 | 3,772 | 3,833 | 3,421 | 2,920 |
EBIT | 5,265 | 6,140 | 6,468 | 6,172 | 4,336 |
EBIT Margin | 14.08% | 16.86% | 18.54% | 19.33% | 16.65% |
Effective Tax Rate | 22.93% | 24.81% | 17.85% | 21.77% | 18.29% |
Revenue as Reported | 38,094 | 37,142 | 35,792 | 32,638 | 26,570 |
Advertising Expenses | - | 193 | 173 | 151 | 90 |